IRadimed Corporation (IRMD) vs Replimune Group, Inc. (REPL)

A side-by-side comparison of IRadimed Corporation and Replimune Group, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
IRadimed Corporation logo
IRMD
IRadimed Corporation
$1.08B
$84.80HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT
Replimune Group, Inc. logo
REPL
Replimune Group, Inc.
$1.09B
$13.01HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT

Total return — IRMD vs REPL

growth of $100 · dividends reinvested · last 8y
IRMD +332.5% (+20.1%/yr)REPL -13.3% (-1.8%/yr)IRMD compounded faster over this window
0100200300400500Start $1002020202220242026$433$87
IRMD REPL

IRMD vs REPL: by the numbers

  • •REPL is the larger company ($1.09B vs $1.08B market cap).
  • •IRMD is profitable (26.70% net margin) while REPL runs a net loss (0.00%).
  • •IRMD pays a dividend (1.47% yield), while REPL has no payments in the available dividend history.

Metrics side by side

Valuation

MetricIRMDREPL
P/E ratio47.37N/A
Forward P/E40.13N/A
PEG ratio0.64N/A
P/S ratio12.56N/A
P/B ratio10.6510.35
EV / EBITDA34.84N/A
FCF yield2.30%N/A

Profitability

MetricIRMDREPL
Gross margin75.86%0.00%
Operating margin31.92%0.00%
Net margin26.70%0.00%
ROE22.66%-281.14%
ROIC20.18%-139.11%

Dividends

MetricIRMDREPL
Dividend yield1.47%N/A
Payout ratio70.95%N/A

Growth (annualized)

MetricIRMDREPL
Revenue CAGR (5Y)19.60%N/A
EPS CAGR (5Y)74.32%N/A
FCF CAGR (5Y)26.20%N/A
Total return CAGR (5Y)24.06%-15.17%

Frequently asked

Does IRMD or REPL pay a bigger dividend?
IRMD pays a dividend (1.47% yield), while REPL has no payments in the available dividend history.
Is IRMD or REPL more profitable?
IRMD runs the higher net margin — IRMD at 26.70% versus REPL at 0.00%.
How have IRMD and REPL total returns compared?
Over the past 5 years, IRMD delivered 24.06% and REPL delivered -15.17% annualized total return. Past performance doesn't predict future results.

Go deeper

Full IRMD analysisFull REPL analysisInteractive comparison tool

Dig into the metrics

IRadimed P/E ratioIRadimed dividend yieldIRadimed ROEReplimune ROEIRadimed operating marginReplimune operating marginIRadimed revenue growthReplimune revenue growthIRadimed free cash flowReplimune free cash flow

IRadimed & Replimune appear in these rankings

Fastest Revenue Growth StocksHighest ROIC StocksHighest Operating Margin StocksHighest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.